Autoimmune, pemphigus, dermatology, medical odyssey, oral health mystery, oral health, blisters, OASIS, Lupus, Sjogren's, ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, explains the strategic advantages of pursuing both a company-sponsored trial and an investigator-initiated trial simultaneously.

The first direct visual evidence of the supermassive black hole in the centre of Messier 87 and its shadow. Event Horizon ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

Artiva Biotherapeutics, Inc.’s ARTV share price has surged by 11.11%, which has investors questioning if this is right time ...

(NASDAQ:ARGX – Free Report) had its price target increased by Guggenheim from $775.00 to $1,100.00 in a report released on Monday morning,Benzinga reports. They currently have a buy rating on the ...

Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost ...

SE (NASDAQ:ARGX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two analysts that are currently covering the company, Marketbeat reports. One analyst has ...

as well as Principia-partnered BTK inhibitor rilzabrutinib for rare autoimmune skin disease pemphigus. It also abandoned an mRNA-based vaccine for COVID-19 and suffered delays to another COVID-19 ...

a Patient had a surgical procedure in April for which his warfarin was discontinued for five days. b During this visit, the patient was prescribed prednisone 10 mg orally daily and his warfarin ...

After hours: March 13 at 7:30:37 PM EDT Loading Chart for ARTV ...

After hours: March 12 at 7:57:29 PM EDT Loading Chart for BIIB ...